| P2093 | author name string | David J Taber | |
| | Kenneth D Chavin | |
| | Prabhakar K Baliga | |
| | Angello Lin | |
| | Nicole A Pilch | |
| | Charles F Bratton | |
| | John W McGillicuddy | |
| | Heather Crego | |
| | Melissa Norcross | |
| P2860 | cites work | Is donor obesity related to liver steatosis and liver graft dysfunction in liver transplantation? | Q30976734 |
| | Primary nonfunction of hepatic allografts with preexisting fatty infiltration | Q34256918 |
| | Hepatic steatosis is not always a contraindication for cadaveric liver transplantation | Q35010235 |
| | Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. | Q35570778 |
| | Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation | Q35745702 |
| | Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings | Q36473567 |
| | When is steatosis too much for transplantation? | Q36571038 |
| | Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. | Q37624925 |
| | Short- and long-term outcomes after steatotic liver transplantation | Q37774181 |
| | Liver transplantation for fatty liver disease | Q37811075 |
| | Liver transplantation using fatty livers: always feasible? | Q37818981 |
| | Use of livers with microvesicular fat safely expands the donor pool | Q39227544 |
| | Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters | Q39905224 |
| | Body mass index as a predictor of hepatic steatosis in living liver donors | Q40708465 |
| | Current practice regarding the use of fatty livers: a trans-Atlantic survey | Q42677328 |
| | Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAst | Q42984139 |
| | Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. | Q42984967 |
| | Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement | Q43288500 |
| | Hepatic steatosis in organ donors: disparity between surgery and histology? | Q44429934 |
| | Use of steatotic graft in living-donor liver transplantation. | Q44527266 |
| | Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. | Q45384068 |
| | Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis | Q45387711 |
| | Expanding postmortem donor pool using steatotic liver grafts: a new look. | Q46081829 |
| | Biological changes after liver transplantation according to the presence or not of graft steatosis | Q46187838 |
| | Reversal of graft steatosis after liver transplantation: prospective study | Q46404856 |
| | Characteristics associated with liver graft failure: the concept of a donor risk index. | Q46734908 |
| | Hepatitis C recurrence: influence of serum cholesterol levels and liver steatosis on antiviral therapy. | Q50557694 |
| | Development of an unbiased method for the estimation of liver steatosis. | Q50782692 |
| | Use of fatty donor liver is associated with diminished early patient and graft survival. | Q50990127 |
| | Safety of donors with fatty liver in liver transplantation. | Q51786066 |
| | Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population? | Q51817319 |
| | Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. | Q53062482 |
| P433 | issue | 5 | |
| P304 | page(s) | 732-741 | |
| P577 | publication date | 2013-09-02 | |
| P1433 | published in | Clinical Transplantation | Q15754920 |
| P1476 | title | Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. | |
| P478 | volume | 27 | |